Kendziora, E. S. (2020). Analysis of urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1), and urokinase plasminogen activator receptor (uPAR) protein expression by immunohistochemistry in triple-negative breast cancer (TNBC).
Chicago-Zitierstil (17. Ausg.)Kendziora, Elena Stephanie. Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-negative Breast Cancer (TNBC). München, 2020.
MLA-Zitierstil (9. Ausg.)Kendziora, Elena Stephanie. Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-negative Breast Cancer (TNBC). 2020.